Sergio Duchini

Sergio Duchini is a highly accomplished leader in the biotechnology and finance sectors, currently serving as Chair of Neurizon Therapeutics, where efforts focus on developing innovative therapies for neurodegenerative diseases. Duchini also holds positions as Non-Executive Director at QBiotics Group Limited and Enlitic, contributing strategic governance and financial oversight. Additionally, memberships on advisory councils and committees, including Medicines Australia and Industry Innovation and Science Australia, highlight a commitment to advancing healthcare and innovation. Past leadership roles include Chairman of Lymphoma Australia, Non-Executive Director at AusBiotech, and a distinguished career at Deloitte, where significant contributions were made in tax services and corporate governance. Educational qualifications include degrees from the University of Melbourne and Harvard Business School, alongside professional designations as a Chartered Accountant and Chartered Tax Adviser.